AKT1 and neoplasm: In vitro experiments demonstrated that overexpression of TUSC7/inhibition of miR-224 repressed cell proliferation and chemotherapy resistance via DESC1/EGFR/AKT pathway, and in vivo experiments demonstrated that overexpression of TUSC7 decreased tumor growth and chemotherapy resistance.